Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • ron.wallach ron.wallach May 13, 2013 11:39 PM Flag

    PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

     

    ok

    Sentiment: Strong Buy

    This topic is deleted.
 
PFE
36.74+0.03(+0.08%)Jul 22 4:00 PMEDT